skip to main content

Muckle LLP supports Sunderland pharma firm in successful sale

23rd May 2019 | Corporate Finance
Muckle LLP supports Sunderland pharma firm in successful sale

We are delighted to have helped the management team of Sunderland based Rokshaw Ltd negotiate the successful sale of its business.

EMMAC Life Sciences Ltd, the European independent medical cannabis company, has announced completion of the acquisition of the entire issued share capital of Rokshaw, the leading UK specials manufacturer, by EMMAC’s UK subsidiary, EMMAC U.K Limited.

Rokshaw’s management team was advised on the corporate finance legal matters by partners Philip Clare and Adam Rayner and solicitor Stuart Grieve.

Medical cannabis imports

Rokshaw is a leading GMP-certified lab, manufacturing a wide range of specials bespoke to patient requirements to ensure that patients across the UK receive the highest quality products.

The acquisition brings immediate revenues to the EMMAC Group and enables EMMAC to import medical cannabis into the UK to meet the rapidly growing demands of the market, led by regulatory change and the increasing requirement for access to premium medical cannabis product.

Rokshaw will become EMMAC’s second GMP-certified lab, working in close conjunction with its research and development facility in Spain.

Inward investment

Antonio Costanzo, CEO of EMMAC, commented: “This investment not only brings with it an immediate revenue stream but also gives EMMAC immediate access to the UK medical cannabis market with the opportunity to grow the existing 45 people-strong team into a centre of medical cannabis excellence for the UK. 

“Joining us are the two founders of Rokshaw who have vital experience working in a highly regulated industry and bring with them a proven commitment to delivering the highest quality products.”

Specialist expertise

Jonathan and Richard Hodgson, co-founders of Rokshaw, said: “We are very pleased to join EMMAC and we share its vision for providing the highest quality products and services to patients across the UK, and unlocking the potential for the medical cannabis market to meet growing clinician and patient demand.

“We were also delighted with the legal support from Muckle LLP. Their specialist pharma expertise and technical skill made our lives so much easier and we don’t believe we could have received this level of support from any other North East law firm.”

To learn more about how we can support your business, please contact Adam

Rayner on 0191 211 7962 or email [email protected].

Share this story...